← All companies

EVO

Evotec SE

EVO Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.94

+0.03 +1.57%

Key statistics

from XBRL data in SEC filings

Market cap

$345M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$1.90 – $4.27

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 14, 2026 6-K FORM 6-K Jun 30, 2026 6-K FORM 6-K Jun 17, 2026 6-K FORM 6-K May 6, 2026 6-K FORM 6-K Apr 30, 2026 6-K FORM 6-K Apr 24, 2026 6-K FORM 6-K Apr 8, 2026 20-F FORM 20-F Apr 8, 2026 6-K FORM 6-K Apr 7, 2026 6-K FORM 6-K Mar 10, 2026 6-K FORM 6-K Jan 16, 2026 6-K FORM 6-K Jan 13, 2026 6-K FORM 6-K Jan 8, 2026 6-K FORM 6-K Jan 6, 2026 6-K FORM 6-K Jan 2, 2026 6-K FORM 6-K Jan 2, 2026 6-K FORM 6-K Dec 8, 2025 6-K FORM 6-K Nov 6, 2025 6-K FORM 6-K Nov 5, 2025 6-K FORM 6-K Nov 5, 2025 6-K FORM 6-K Aug 13, 2025 6-K FORM 6-K Jul 30, 2025 6-K FORM 6-K Jul 21, 2025 6-K FORM 6-K Jun 3, 2025 6-K FORM 6-K May 6, 2025 20-F FORM 20-F Apr 17, 2025 6-K FORM 6-K Apr 17, 2025 6-K FORM 6-K Apr 17, 2025 6-K FORM 6-K Nov 29, 2024 6-K FORM 6-K Nov 22, 2024 6-K FORM 6-K Nov 15, 2024 6-K FORM 6-K Nov 6, 2024 6-K FORM 6-K Aug 14, 2024 20-F FORM 20-F Aug 14, 2024 6-K FORM 6-K Aug 6, 2024 6-K FORM 6-K Jun 10, 2024 6-K FORM 6-K May 22, 2024 6-K FORM 6-K Apr 24, 2024 6-K FORM 6-K Apr 23, 2024 6-K FORM 6-K Apr 8, 2024